177 related articles for article (PubMed ID: 36752371)
1. Abbreviated Versus Full-Protocol MRI for Breast Cancer Neoadjuvant Chemotherapy Response Assessment: Diagnostic Performance by General and Breast Radiologists.
Tang WJ; Chen SY; Hu WK; Li XL; Zheng BJ; Wang ZS; Ding HJ; Chen LX; Zhang QQ; Yu XM; Sui Y; Wei XH; Guo Y
AJR Am J Roentgenol; 2023 Jun; 220(6):817-825. PubMed ID: 36752371
[No Abstract] [Full Text] [Related]
2. MRI Screening of
Naranjo ID; Sogani J; Saccarelli C; Horvat JV; Sevilimedu V; Hughes MC; Gullo RL; Jochelson MS; Reiner J; Pinker K
AJR Am J Roentgenol; 2022 May; 218(5):810-820. PubMed ID: 34935399
[No Abstract] [Full Text] [Related]
3. Abbreviated screening protocol for breast MRI: a feasibility study.
Grimm LJ; Soo MS; Yoon S; Kim C; Ghate SV; Johnson KS
Acad Radiol; 2015 Sep; 22(9):1157-62. PubMed ID: 26152500
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of abbreviated breast MRI protocols using 1.5 T MRI in the preoperative staging of newly diagnosed breast cancers.
Kadioglu ME; Metin Y; Metin NO; Tasci F; Ozdemir O; Kupeli A
Clin Imaging; 2023 Sep; 101():44-49. PubMed ID: 37295233
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes.
Kim J; Han BK; Ko EY; Ko ES; Choi JS; Park KW
Eur Radiol; 2022 Jun; 32(6):4056-4066. PubMed ID: 34989844
[TBL] [Abstract][Full Text] [Related]
6. MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
Goorts B; Dreuning KMA; Houwers JB; Kooreman LFS; Boerma EG; Mann RM; Lobbes MBI; Smidt ML
Breast Cancer Res; 2018 Apr; 20(1):34. PubMed ID: 29669584
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
Kim Y; Sim SH; Park B; Lee KS; Chae IH; Park IH; Kwon Y; Jung SY; Lee S; Ko K; Kang HS; Lee CW; Lee ES
Clin Breast Cancer; 2018 Dec; 18(6):459-467.e1. PubMed ID: 29954674
[TBL] [Abstract][Full Text] [Related]
8. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
[No Abstract] [Full Text] [Related]
9. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
[No Abstract] [Full Text] [Related]
11. Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.
Sutton EJ; Braunstein LZ; El-Tamer MB; Brogi E; Hughes M; Bryce Y; Gluskin JS; Powell S; Woosley A; Tadros A; Sevilimedu V; Martinez DF; Toni L; Smelianskaia O; Nyman CG; Razavi P; Norton L; Fung MM; Sedorovich JD; Sacchini V; Morris EA
JAMA Netw Open; 2021 Jan; 4(1):e2034045. PubMed ID: 33449096
[TBL] [Abstract][Full Text] [Related]
12. Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study.
Yirgin IK; Engin G; Yildiz Ş; Aydin EC; Karanlik H; Cabioglu N; Tukenmez M; Emiroglu S; Onder S; Yildiz SO; Yavuz E; Saip P; Aydiner A; Igci A; Muslumanoglu M
Curr Med Imaging; 2022; 18(10):1052-1060. PubMed ID: 35209823
[TBL] [Abstract][Full Text] [Related]
13. Abbreviated MRI of the foot in patients with suspected osteomyelitis.
Kotecha HM; Lo HS; Vedantham S; Shin H; Cerniglia CA
Emerg Radiol; 2020 Feb; 27(1):9-16. PubMed ID: 31463805
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and potential limitations of abbreviated breast MRI: an observer study using an enriched cohort.
Machida Y; Shimauchi A; Kanemaki Y; Igarashi T; Harada M; Fukuma E
Breast Cancer; 2017 May; 24(3):411-419. PubMed ID: 27485755
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic performance of abbreviated MRI and full diagnostic MRI using a computer-aided diagnosis (CAD) system in patients with a personal history of breast cancer: the effect of CAD-generated kinetic features on reader performance.
Ha T; Jung Y; Kim JY; Park SY; Kang DK; Kim TH
Clin Radiol; 2019 Oct; 74(10):817.e15-817.e21. PubMed ID: 31362885
[TBL] [Abstract][Full Text] [Related]
16. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of
Hunt KN; Conners AL; Goetz MP; O'Connor MK; Suman V; Kalari K; Weinshilboum R; Wang L; Carter J; McLaughlin S; Aspitia AM; Gray R; Northfelt D; Boughey JC
AJR Am J Roentgenol; 2019 Oct; 213(4):932-943. PubMed ID: 31166752
[No Abstract] [Full Text] [Related]
18. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?
Sella T; Simor B; Adler-Levy Y; Maly B; Kadouri L; Carmon E
Eur Radiol; 2023 Oct; 33(10):7168-7177. PubMed ID: 37086288
[TBL] [Abstract][Full Text] [Related]
19. Implementation of abbreviated breast MRI in diagnostic and screening settings.
Ahmadinejad N; Azhdeh S; Arian A; Eslami B; Mehrabinejad MM
Acta Radiol; 2023 Mar; 64(3):987-992. PubMed ID: 35938611
[TBL] [Abstract][Full Text] [Related]
20. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
Choi BB; Kim SH
Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
